These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30442186)

  • 1. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
    Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
    Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.
    Peter EL; Mtewa AG; Nagendrappa PB; Kaligirwa A; Sesaazi CD
    Syst Rev; 2020 Jan; 9(1):7. PubMed ID: 31915054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
    Peter EL; Kasali FM; Deyno S; Mtewa A; Nagendrappa PB; Tolo CU; Ogwang PE; Sesaazi D
    J Ethnopharmacol; 2019 Mar; 231():311-324. PubMed ID: 30385422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007845. PubMed ID: 20166099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.
    Peter EL; Nagendrappa PB; Kaligirwa A; Ogwang PE; Sesaazi CD
    Phytother Res; 2021 Feb; 35(2):637-656. PubMed ID: 32929814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
    Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
    J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol.
    Wang X; Liu J; Huang L; Zeng H; He G; Chen L; Ma R; Fu W; Ning B
    BMJ Open; 2019 Oct; 9(10):e029073. PubMed ID: 31594873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol.
    Liu Y; Liu X; R Lewis J; Brock K; C Brennan-Speranza T; Teixeira-Pinto A
    BMJ Open; 2019 Mar; 9(3):e023918. PubMed ID: 30862632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of randomized cross-over controlled trials.
    Hu H; Lei Y; Yin L; Luo X
    Medicine (Baltimore); 2020 Nov; 99(47):e22735. PubMed ID: 33217794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials.
    Sun YN; Zhou Y; Chen X; Che WS; Leung SW
    Syst Rev; 2013 Nov; 2():103. PubMed ID: 24225054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
    Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
    Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis.
    Chen M; Xie CG; Gao H; Zheng H; Chen Q; Fang JQ
    BMJ Open; 2016 Jan; 6(1):e010252. PubMed ID: 26826156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.
    Efird JT; Choi YM; Davies SW; Mehra S; Anderson EJ; Katunga LA
    Int J Environ Res Public Health; 2014 Feb; 11(2):2328-45. PubMed ID: 24566057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Chinese herbal medicine on blood glucose fluctuations in patients with type 2 diabetes mellitus: A protocol of systematic review and meta-analysis.
    Leng Y; Zhou X; Xie Z; Hu Z; Gao H; Liu X; Xie H; Fu X; Xie C
    Medicine (Baltimore); 2020 Aug; 99(34):e21904. PubMed ID: 32846855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study.
    Rauniyar GP; Sinha R; Chapagain K; Maskey R; Pandey DR
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):143-147. PubMed ID: 34819444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocol.
    Gourlay A; Sutherland C; Radley A
    BMJ Open; 2023 May; 13(5):e072882. PubMed ID: 37173112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials.
    Zhou F; Deng J; Banfield L; Thabane L; Sadeghirad B; Samaan MC
    BMJ Open; 2022 Sep; 12(9):e065287. PubMed ID: 36167361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.